We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Teladoc (TDOC) Registers a Bigger Fall Than the Market: Important Facts to Note
Read MoreHide Full Article
In the latest trading session, Teladoc (TDOC - Free Report) closed at $6.13, marking a -3.46% move from the previous day. The stock's change was less than the S&P 500's daily loss of 0.76%. On the other hand, the Dow registered a loss of 0.68%, and the technology-centric Nasdaq decreased by 1.13%.
Prior to today's trading, shares of the telehealth services provider had gained 2.58% outpaced the Medical sector's loss of 3.03% and the S&P 500's gain of 1.26%.
Investors will be eagerly watching for the performance of Teladoc in its upcoming earnings disclosure. The company's earnings per share (EPS) are projected to be -$0.23, reflecting a 9.52% decrease from the same quarter last year. Meanwhile, the latest consensus estimate predicts the revenue to be $585.55 million, indicating a 6.53% decrease compared to the same quarter of the previous year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of -$0.92 per share and revenue of $2.4 billion. These totals would mark changes of +19.3% and -5.03%, respectively, from last year.
Investors should also pay attention to any latest changes in analyst estimates for Teladoc. Such recent modifications usually signify the changing landscape of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 1.78% lower. At present, Teladoc boasts a Zacks Rank of #3 (Hold).
The Medical Services industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 88, placing it within the top 36% of over 250 industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.
View the Zacks #1 Rank List
Image: Bigstock
Teladoc (TDOC) Registers a Bigger Fall Than the Market: Important Facts to Note
In the latest trading session, Teladoc (TDOC - Free Report) closed at $6.13, marking a -3.46% move from the previous day. The stock's change was less than the S&P 500's daily loss of 0.76%. On the other hand, the Dow registered a loss of 0.68%, and the technology-centric Nasdaq decreased by 1.13%.
Prior to today's trading, shares of the telehealth services provider had gained 2.58% outpaced the Medical sector's loss of 3.03% and the S&P 500's gain of 1.26%.
Investors will be eagerly watching for the performance of Teladoc in its upcoming earnings disclosure. The company's earnings per share (EPS) are projected to be -$0.23, reflecting a 9.52% decrease from the same quarter last year. Meanwhile, the latest consensus estimate predicts the revenue to be $585.55 million, indicating a 6.53% decrease compared to the same quarter of the previous year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of -$0.92 per share and revenue of $2.4 billion. These totals would mark changes of +19.3% and -5.03%, respectively, from last year.
Investors should also pay attention to any latest changes in analyst estimates for Teladoc. Such recent modifications usually signify the changing landscape of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 1.78% lower. At present, Teladoc boasts a Zacks Rank of #3 (Hold).
The Medical Services industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 88, placing it within the top 36% of over 250 industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.